GSTP1 and prostate cancer: In case of one of the best characterized biomarkers, GSTP1, a meta study (mainly using prostatectomy tissue or prostate sextant biopsies) showed that hypermethylation of the promoter allows to diagnose prostate cancer with a sensitivity of 82% and a specificity of 95% [72].